Core Laboratories N.v. (CLB) Tops Q4 EPS by 4c; Guides Q1, FY13

January 30, 2013 5:39 PM

Core Laboratories N.v. (NYSE: CLB) reported Q4 EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found